Department of Laboratory Medicine, Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing, China.
Crit Rev Clin Lab Sci. 2024 Jun;61(4):298-316. doi: 10.1080/10408363.2023.2291379. Epub 2023 Dec 26.
Evidence derived from laboratory medicine plays a pivotal role in the diagnosis, treatment monitoring, and prognosis of various diseases. Reference intervals (RIs) are indispensable tools for assessing test results. The accuracy of clinical decision-making relies directly on the appropriateness of RIs. With the increase in real-world studies and advances in computational power, there has been increased interest in establishing RIs using big data. This approach has demonstrated cost-effectiveness and applicability across diverse scenarios, thereby enhancing the overall suitability of the RI to a certain extent. However, challenges persist when tests results are influenced by age and sex. Reliance on a single RI or a grouping of RIs based on age and sex can lead to erroneous interpretation of results with significant implications for clinical decision-making. To address this issue, the development of next generation of reference interval models has arisen at an historic moment. Such models establish a curve relationship to derive continuously changing reference intervals for test results across different age and sex categories. By automatically selecting appropriate RIs based on the age and sex of patients during result interpretation, this approach facilitates clinical decision-making and enhances disease diagnosis/treatment as well as health management practices. Development of next-generation reference interval models use direct or indirect sampling techniques to select reference individuals and then employed curve fitting methods such as splines, polynomial regression and others to establish continuous models. In light of these studies, several observations can be made: Firstly, to date, limited interest has been shown in developing next-generation reference interval models, with only a few models currently available. Secondly, there are a wide range of methods and algorithms for constructing such models, and their diversity may lead to confusion. Thirdly, the process of constructing next-generation reference interval models can be complex, particularly when employing indirect sampling techniques. At present, normative documents pertaining to the development of next-generation reference interval models are lacking. In summary, this review aims to provide an overview of the current state of development of next-generation reference interval models by defining them, highlighting inherent advantages, and addressing existing challenges. It also describes the process, advanced algorithms for model building, the tools required and the diagnosis and validation of models. Additionally, a discussion on the prospects of utilizing big data for developing next-generation reference interval models is presented. The ultimate objective is to equip clinical laboratories with the theoretical framework and practical tools necessary for developing and optimizing next-generation reference interval models to establish next-generation reference intervals while enhancing the use of medical data resources to facilitate precision medicine.
实验室医学所提供的证据在各种疾病的诊断、治疗监测和预后评估中起着关键作用。参考区间(RI)是评估检验结果不可或缺的工具。临床决策的准确性直接取决于 RI 的适当性。随着真实世界研究的增加和计算能力的提高,人们越来越感兴趣地使用大数据来建立 RI。这种方法在各种情况下都具有成本效益和适用性,从而在一定程度上提高了 RI 的整体适用性。然而,当检验结果受到年龄和性别影响时,仍然存在挑战。依赖单一的 RI 或基于年龄和性别的 RI 分组可能导致对结果的错误解释,这对临床决策有重大影响。为了解决这个问题,新一代参考区间模型的发展应运而生。这些模型建立了曲线关系,可以为不同年龄和性别组的检验结果得出连续变化的参考区间。通过在解释结果时根据患者的年龄和性别自动选择适当的 RI,这种方法促进了临床决策,并增强了疾病诊断/治疗以及健康管理实践。新一代参考区间模型的开发使用直接或间接采样技术来选择参考个体,然后使用样条、多项式回归等曲线拟合方法来建立连续模型。基于这些研究,可以得出以下几点观察结果:首先,迄今为止,人们对开发新一代参考区间模型的兴趣有限,目前只有少数几个模型可用。其次,构建此类模型的方法和算法种类繁多,可能会令人困惑。第三,构建新一代参考区间模型的过程可能很复杂,特别是在使用间接采样技术时。目前,缺乏关于开发新一代参考区间模型的规范文件。总之,本综述旨在通过定义、突出内在优势和解决现有挑战,概述新一代参考区间模型的当前发展状况。它还描述了模型构建的过程、高级算法、所需的工具以及模型的诊断和验证。此外,还讨论了利用大数据开发新一代参考区间模型的前景。最终目标是为临床实验室提供开发和优化新一代参考区间模型所需的理论框架和实用工具,以建立新一代参考区间,同时利用医疗数据资源促进精准医学。